Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
A photon-counting CT system uses a photon-counting detector (PCD) to track individual photon interactions. The detector pixels of a PCD each record an approximate energy spectrum by keeping track of the deposited energy in each interaction, making it a spectral or energy-resolved CT approach. On the other hand, Typical CT scanners, use energy-integrating detectors (EIDs), which register the overall energy from a large number of photons as well as electronic noise deposited in a pixel over a set period of time. Typical CT detectors therefore register only photon intensity, comparable to black-and-white photography, whereas photon-counting detectors register also spectral information, similar to color photography. When a photon interacts in a PCD, the height of the resulting electrical pulse is roughly proportional to the photon energy. By comparing each pulse made in a pixel with an appropriate low-energy threshold, contributions from low-energy events resulting from both photon interactions and electronic noise are often filtered out. This effectively eliminates contributions from electronic noise at the expense of discarding photons with energy comparable to the noise level.
The growing demand for early detection of chronic diseases is propelling the growth of photon-counting CT market. Changing lifestyle and adoption of unhealthy habits such as tobacco use and smoking along with rising levels of air pollution, will lead to a rise in cancer prevalence which will also stimulates the growth of photon counting CT market. For accurate illness diagnosis, a photon-counting CT scanner is used. Furthermore, rising demand for premium healthcare infrastructure, as well as major advancements in imaging technology are expected to propel the growth of the photon-counting CT market.
The exclusive COVID-19 impact analysis report by Axiom MRC provides a 360 degree analysis of micro and macro-economic factors on the photon counting CT market. In addition, complete analysis of changes on the photon counting CT market expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on Global economies, international trade, business investments, GDP and marketing strategies of key players present in the market. The global photon-counting CT had negative impact, due to global lockdown the movement of patients for routine check-ups was disturbed.
Photon Counting CT market is segmented into product type, application and end user and geography.
By product type, photon counting CT market is segmented into single channel counting system and multichannel counting system. The single channel counting system segment is expected to hold a major share in the global photon-counting CT market. Single-photon detectors are important in many disciplines of research, including biology, chemistry, medicine, and space technology, and single-photon avalanche diodes (SPADs) have recently emerged as a viable alternative to photo multiplier tubes (PMTs). Also the multichannel counting system is expected to grow in the forecast period as it leads to enhanced sensitivity, detection limits and reduced analysis time. Multichannel acquisition can improve analysis of fast transient signals such as those produced by gas or liquid chromatography.
There are various applications in photon counting CT market such as cardiology oncology, neurology and others. The cardiology segment is likely to dominate the global photon-counting CT market in 2020. Owing to the rising demand for early diagnosis of cardiac disorders. The growing demand for early identification of chronic diseases globally is propelling the cardiology segment in the photon-counting CT market forward. Changes in lifestyle choices such as tobacco use and smoking as well as rising levels of air pollution, will all contribute to a rise in cancer prevalence. The rising prevalence of cardiac disease is likely to boost the growth of cardiology segment in the forecast period 2021-2027.
The photon counting CT market finds its major end user in hospitals, specialty clinics, imaging and research centers. The hospitals segment is likely to dominate the global photon-counting CT market as they serve as the primary center for disease diagnosis and treatment. Witnessing to the number of increasing lung infection cases the hospitals segment is expected to dominate the market in the forecast period. Furthermore, the photon-counting CT market is expected to rise due to rising demand for premium healthcare infrastructure and major advancements in imaging technology.
The global photon counting CT market is studied for the following region North America, Europe, Asia-Pacific and Rest of the world (RoW). North America is expected to gain major share in the global photon-counting CT market due to the quick implementation and adoption of advanced technology and the rising introduction of various medical devices for early diagnosis and treatment. Europe is expected to hold the second position in the global photon counting CT market. According to European Union, the number of people newly diagnosed with cancer every year in Europe is increasing at a fast pace. Also Asia Pacific is expected to grow at a faster pace in the global photon-counting CT market due to the rising geriatric population and healthcare expenditure.
The key players in Photon Counting CT Market are Picoquant, Becker & Hickl Gmbh, Hidex Oy, Id, Quantique (Idq), Photek, Thorlabs Inc., Ge Healthcare among others.
November 2020: GE Healthcare (NYSE:GE) announced that it has acquired Prismatic Sensors, a Swedish startup with deep silicon detector technology for photon-counting computed tomography (PCCT). Photon-counting CT technology, according to GE Healthcare, it could expand the clinical capabilities of traditional CT for providing diagnostic benefits in clinical areas including oncology, cardiology and neurology. PCCT can enable the visualization of minute organ structure details, improved tissue characterization and more accurate material density measurement (or quantification). Plus, the radiation dose is lower.
September 2020: PicoQuant’s rapidFLIM HiRes combines ultra-fast FLIM imaging with outstanding 10 ps time resolution. Users can now visualize dynamic processes in cells or tissues with unprecedented acquisition speed and time resolution. Imaging dynamic processes in tissues or cells require methods that are fast, reliable, and quantitative. Scientists and engineers at PicoQuant have developed rapidFLIM HiRes which enables imaging samples at up to 15 frames per second with a time resolution of 10 ps using Fluorescence Lifetime Imaging (FLIM).
The report analyses the photon counting CT market based on different market segments like product type, application and end user and geography. By product type photon counting CT market is segmented into single channel counting system and multichannel counting system. The single channel counting system segment is expected to gain a major share in the global photon-counting CT market due to its wide application in biology, chemistry, medicine, and space technology, and single-photon avalanche diodes (SPADs). Also the multichannel counting system is expected to grow in the forecast period as it leads to enhanced sensitivity, detection limits, and reduced analysis time. By application the photon counting CT market includes cardiology oncology, neurology and others. The cardiology segment is likely to dominate the global photon-counting CT market due to the increasing demand for early diagnosis of cardiac disorders, imbalanced lifestyle and changes in lifestyle choices such as tobacco use and smoking, are contribute to a rise in the number of cancer cases. By end users the photon counting CT market finds its major end user in hospitals, specialty clinics, imaging and research centers. The hospitals segment is likely to dominate the global photon-counting CT market as they serve as the primary center for disease diagnosis and treatment. The global photon counting CT market is studied for the following region North America, Europe, Asia-Pacific and Rest of the world (RoW). North America is expected to gain major share in the global photon-counting CT market due to the quick implementation and adoption of advanced technology. Europe holds the second position and following the Asia Pacific photon counting CT market is expected to grow at increasing pace in the forecast period.
